Ventyx Biosciences Chief Medical Officer William Sandborn receives $7.5M in 2022
Ventyx Biosciences reports 2022 executive compensation
By ExecPay News
Published: April 26, 2023
Ventyx Biosciences reported fiscal year 2022 executive compensation information on April 26, 2023.
In 2022, three executives at Ventyx Biosciences received on average a compensation package of $4.4M, a 40% decrease compared to previous year.
William J. Sandborn, Chief Medical Officer, received $7.5M in total. 88% of Sandborn's compensation, or $6.6M, was in option awards. Sandborn also received $175K in bonus, $338K in non-equity incentive plan, $323K in salary, as well as $37K in other compensation.
Raju Mohan, Chief Executive Officer, received a compensation package of $4M, which decreased by 73% compared to previous year. 75% of the compensation package, or $3M, was in option awards.
John Nuss, Chief Scientific Officer, earned $1.8M in 2022, a 63% decrease compared to previous year.